Lipotoxicity and Maintenance of Metabolic Health

NIH RePORTER · NIH · R01 · $573,863 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Lipotoxicity is an important mechanism of complications in type 2 diabetes, including non-alcoholic fatty liver disease (NAFLD). Through a genetic screen, we discovered that loss of small nucleolar RNAs (snoRNAs) embedded within introns of the ribosomal protein L13a (Rpl13a) locus confers resistance to lipotoxicity in a cell culture model. The four Rpl13a snoRNAs, SNORD32A, SNORD33, SNORD34, and SNORD35A, guide 2¢-O- methyl nucleotide modifications at five sites on nascent 18S and 28S ribosomal RNAs that lie in close proximity to key functional centers of the ribosome structure. This study will test the hypothesis that knockout of Rpl13a snoRNAs protects from lipotoxic tissue damage in a mouse model of high fat diet-induced NAFLD. We will define the mechanistic links among snoRNA abundance, mRNA translation, and dietary nutrient exposures. Findings from this work will provide new insights into the pathophysiology of NAFLD and other diseases of lipid overload and have the potential to identify new therapeutic targets for treatment of metabolic diseases.

Key facts

NIH application ID
10873823
Project number
5R01DK137511-02
Recipient
JOSLIN DIABETES CENTER
Principal Investigator
JEAN E. SCHAFFER
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$573,863
Award type
5
Project period
2023-07-01 → 2027-04-30